XML 121 R98.htm IDEA: XBRL DOCUMENT v3.6.0.2
QUARTERLY FINANCIAL DATA (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Quarterly Financial Data [Abstract]                      
Net revenues $ 207,101 $ 126,706 $ 175,206 $ 129,000 $ 195,552 $ 117,322 $ 166,834 $ 126,133 $ 638,013 $ 605,841 $ 680,793
Cost of revenues 119,946 91,141 104,962 97,777 116,654 85,832 101,229 98,828 413,826 402,543 489,041
Operating income 51,551 8,384 43,891 7,763 46,528 28,853 36,441 (17,239) 111,589 94,583 38,280
Net (loss) / income 21,169 (19,823) (141,249) (40,694) 1,137 (21,510) (11,669) (70,243) (180,597) (102,285) (151,465)
Loss from discontinued operations, net of tax         (12,418) (265) 2,684 (3,288) 0 (13,287) (80,431)
Net loss 21,169 (19,823) (141,249) (40,694) (11,281) (21,775) (8,985) (73,531) (180,597) (115,572) (231,896)
Net (loss) / income attributable to CME Ltd. $ 21,088 $ (19,627) $ (141,317) $ (40,435) $ (11,427) $ (21,522) $ (8,678) $ (73,274) $ (180,291) $ (114,901) $ (227,428)
Net (loss) / income per share:                      
Basic EPS (in dollars per share) $ 0.07 $ (0.14) $ (0.98) $ (0.31) $ (0.11) $ (0.18) $ (0.09) $ (0.53) $ (1.28) $ (0.90) $ (1.66)
Effect of dilutive securities (in dollars per share) (0.01) 0.00 0.00 0.00 0.00 0.00 0.00 0.00      
Diluted (in dollars per share) $ 0.06 $ (0.14) $ (0.98) $ (0.31) $ (0.11) $ (0.18) $ (0.09) $ (0.53) $ (1.28) $ (0.90) $ (1.66)